Rapid test for the determination of the nucleocapsid antigen of the SARS-CoV-2 virus and antigens of influenza A and B viruses by immunochromatographic analysis - Rapid test SARS-CoV-2-Influenza A / B-Antigen, TU BY 100185093-087-2022 - Belarus Medical Device Registration

Access comprehensive regulatory information for Rapid test for the determination of the nucleocapsid antigen of the SARS-CoV-2 virus and antigens of influenza A and B viruses by immunochromatographic analysis - Rapid test SARS-CoV-2-Influenza A / B-Antigen, TU BY 100185093-087-2022 in the Belarus medical device market through Pure Global AI's free database. This Medical devices medical device is manufactured by Self-supporting pilot production of the Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus UNP:100185093. The device was registered on December 05, 2022.

This page provides complete registration details including manufacturer information, product type classification, authorized representative details, and regulatory compliance data from the official Belarus medical device database. Pure Global AI offers free access to Belarus's medical device registry, helping global MedTech companies navigate Belarus regulations efficiently.